Anthony John Sabino - Mar 15, 2024 Form 4 Insider Report for LIVEPERSON INC (LPSN)

Role: Chief Executive Officer, Director
Signature: /s/ Monica L. Greenberg, Attorney-in-Fact for Anthony John Sabino
Stock symbol: LPSN
Transactions as of: Mar 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/19/2024, 09:34 PM
Previous filing: Jan 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LPSN	Common Stock	Award	$0	+2.58M		$0.00	2.58M	Mar 15, 2024	Direct	F1
transaction	LPSN	Common Stock	Award	$0	+774K	+30%	$0.00	3.35M	Mar 15, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPSN	Stock Option (Right to Buy)	Award	$0	+1M		$0.00	1M	Mar 15, 2024	Common Stock	1M	$1.02	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 2,580,645 restricted stock units ("RSU"s) under the terms of the LivePerson, Inc. 2018 Inducement Plan (the "Plan"), and each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date, 25% of the RSU's are scheduled to vest on March 15, 2025, and 6.25% of the RSU's are scheduled to vest in equal quarterly installments thereafter, so that 100% of the RSUS will be fully vested on March 15, 2028.
F2	The Reporting Person was granted 774,194 RSUs under the terms of the Plan, and each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued employment with the Issuer through the applicable date, 50% of the RSUs are scheduled to vest on March 15, 2025, and 50% of the RSUs are scheduled to vest on March 15, 2026, so that 100% of the RSUs will be fully vested on March 15, 2026.
F3	The Reporting Person was granted an option to purchase 1,000,000 shares of the Issuer's common stock under the terms of the Plan. Subject to the Reporting Person's continued employment with the Issuer through the applicable date, the option will become exercisable, if at all, when the performance-based and time-based conditions are met. The option will become exercisable in two equal installments if the average closing price of the Issuer's common stock on the NASDAQ exceeds $8 and $13, respectively, for 30 rolling trading days, prior to January 10, 2027, and January 10, 2028, respectively. To the extent the foregoing performance-based conditions are met, 50% of the option will be exercisable on March 15, 2026, and 1/24th of the option will be exercisable in equal monthly installments thereafter.